Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-02

Clinical Trial Update: To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Ganilever PFS and Orgalutran in Controlled Ovarian Stimulation to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganilever PFS
  • Orgalutran (ganirelix)

Snippet

Sponsor: LG Life Sciences | Conditions: Controlled Ovarian Stimulation | Phase 4 | Status: COMPLETED